Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects
2016 · The Journal of Clinical Pharmacology · 43 citations
https://doi.org/10.1002/jcph.791
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
2.8K
Citations
22
h-index
27
i10-index
Marek Honczarenko is an academic researcher. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Chemokine receptors and signaling & Acute Lymphoblastic Leukemia research. The author has an h-index of 22, co-authored 47 publications.
Click to start Chat